Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T20:41:55.483Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T20:41:55.483Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5f3696a2d024229c19dd1691f2f438020e28c75ff27c8cf4c9d796e14bd4a3b5
FORWARD PE RATIO
N/A
iTonic Holdings Ltd.
Market Cap
$28.10M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| iTonic Holdings Ltd. (ITOC) | $28.10M | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.31M | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | N/A |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A |
| Tevogen Bio Holdings Inc. (TVGN)vs › | $27.03M | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | N/A |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A |
| GridAI Technologies Corp. (GRDX)vs › | $29.74M | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $29.91M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
